Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$198.21 - $248.9 $166,892 - $209,573
842 New
842 $209,000
Q1 2020

May 15, 2020

SELL
$115.75 - $170.96 $1.57 Million - $2.33 Million
-13,605 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$130.23 - $153.27 $125,020 - $147,139
-960 Reduced 6.59%
13,605 $1.88 Million
Q3 2019

Nov 14, 2019

SELL
$134.24 - $148.53 $402,720 - $445,590
-3,000 Reduced 17.08%
14,565 $1.99 Million
Q1 2019

May 15, 2019

BUY
$111.86 - $136.3 $190,162 - $231,710
1,700 Added 10.72%
17,565 $2.06 Million
Q3 2018

Nov 14, 2018

BUY
$123.14 - $138.52 $270,908 - $304,744
2,200 Added 16.1%
15,865 $2.1 Million
Q4 2017

Feb 14, 2018

SELL
$135.02 - $162.6 $162,024 - $195,120
-1,200 Reduced 8.07%
13,665 $2.13 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,865
14,865 $2.45 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Euclidean Technologies Management, LLC Portfolio

Follow Euclidean Technologies Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Technologies Management, LLC with notifications on news.